News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-12-14 1:6:27 pm Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024 GlobeNewsWire
2023-12-11 1:5:0 pm Sutro Biopharma Announces New Positive Data from the Compassionate Use of Luveltamab Tazevibulin (luvelta) in Pediatric Patients with Relapsed/Refractory CBF/GLIS Presented at ASH 2023 GlobeNewswire
2023-12-04 1:5:0 pm Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit GlobeNewswire
2023-11-27 1:0:0 pm Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates GlobeNewswire
2023-11-21 1:5:0 pm Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer GlobeNewswire
2023-11-13 2:12:3 pm Sutro Biopharma Inc (STRO) Reports Q3 2023 Financial Results and Business Updates GuruFocus.com
2023-11-13 1:30:0 pm Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones GlobeNewswire
2023-11-13 5:32:0 am Why Sutro Biopharma (STRO) Might Surprise This Earnings Season Zacks
2023-11-04 7:26:53 am Sutro Biopharma (NASDAQ:STRO) shareholders are up 11% this past week, but still in the red over the last three years Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information